IEQ Capital’s Rocket Pharmaceuticals RCKT Stock Holding History

IEQ Capital’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$460K	Sell	174,911 -265,344	-60%	-$920K	﹤0.01%	1414
2026 Q2	$1.51M	Buy	440,255 +58,416	+15%	+$194K	0.01%	932
2026 Q1	$1.37M	Buy	381,839 +343,312	+891%	+$1.36M	0.01%	915
2025 Q4	$135K	Sell	38,527 -42,650	-53%	-$146K	﹤0.01%	1739
2025 Q3	$265K	Buy	81,177 +42,125	+108%	+$133K	﹤0.01%	1572
2025 Q2	$95.7K	Buy	39,052 +14,777	+61%	+$74.9K	﹤0.01%	1721
2025 Q1	$162K	Buy	+24,275	New	+$240K	﹤0.01%	1417

Other funds holding RCKT

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Privium Fund Management Amsterdam, Netherlands $516M AUM 18.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

IEQ Capital's RCKT Position: Q3 2026 in Review

IEQ Capital reduced its Rocket Pharmaceuticals (RCKT) stake by 60% in Q3 2026, selling an estimated $920K and leaving 174,911 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #1414.

IEQ Capital first reported a position in RCKT in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.51M in Q2 2026. 74 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.

IEQ Capital held 174,911 shares of Rocket Pharmaceuticals worth $460K as of Q3 2026.
IEQ Capital sold 265,344 Rocket Pharmaceuticals shares in Q3 2026, an estimated $920K.
Rocket Pharmaceuticals made up ﹤0.01% of IEQ Capital's portfolio in Q3 2026, its #1414 holding.
IEQ Capital first reported a position in Rocket Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
IEQ Capital's Rocket Pharmaceuticals position peaked at $1.51M in Q2 2026.
74 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.

Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.